BioValley France launches a CEI in the field of atopic dermatitis – apply before 28/06/2021!



Supported by the French Eczema Association and the Dermatology Therapeutic Education Group, with the institutional support of Lilly France, BioValley France is launching a call for expressions of interest aimed at startups and SMEs to improve the course of treatment for atopic dermatitis (eczema).

Startups and SMEs in the health sector established in France can help improve the care process with their disruptive innovations in eHealth!

Launched within the framework of the Future Investments Programme (PIA), and more specifically the e-Health Challenges scheme (DSN), this call for expressions of interest (CEI) aims to improve care options (patient care and optimising the course of treatment) and to reduce the costs of health care in France. The CEI was proposed by the Grand Est BioValley France health cluster in response to the Digital Challenges launched by the French government in 2017. The first step of the DSN is to identify the areas of weakness and difficulty experienced by patients and health professionals in the field of eczema.

Find out more